Skip to main content

Advertisement

Table 3 Baseline patient characteristics

From: Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials

  Control Intervention
(n = 70) (n = 58)
Mean age (range) 58 (41 – 74) 57 (41 – 78)
 White race 56% 53%
 Education: 70% 65%
At least some college
Marital Status: 59% 64%
 Married
Personal Doctor 96% 96%
FH of Prostate Cancer 13% 4%
Discussed PSA with MD in last 12 months 51% 41%
Prior MD recommendation for screening 22% 14%
Previous PSA Screening (ever) 59% 44%
Previous Abnormal PSA 10% 7%
Plan for PSA Screening in next 12 months 80% 69%
Think PSA Screening is a Decision 17% 34%
Have Key Knowledge about PSA Decision* 10% 3%
Preferred Participation in DM:   
 I decide 16% 25%
 Share decision 77% 71%
 MD decides 7% 4%
Decisional Conflict, uncertainty score (sd)† 1.9 (0.8) 1.9 (0.8)
  1. * Key knowledge: Agreement with the following four statements: 1) Some men can live long lives with prostate cancer, 2) most men diagnosed as prostate cancer die of something else, 3) problems with sexual function is a common side effect of prostate cancer treatments, and 4) problems with urination is a common side effect of prostate cancer treatments.
  2. †Decisional Conflict, uncertainty score: Mean agreement on 1–5 scale for the following 3 questions: 1) The decision is easy for me to make, 2) I am sure what to do in this decision, 3) It is clear what choice is best for me.